ELAPR002f Injectable Gel

· AbbVie

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ELAPR002f Injectable Gel, covering 2025-03-05 to 2026-08-17. Get the full timeline:

Most recent: Clinical Trial Update: ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars [Phase 3]